Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Tanasi

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
British Journal of Haematology|September 13, 2023
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL studyDarina Ocadlikova, Federico Lussana, Nicola Fracchiolla, et al.
Cancer Medicine|January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA ProjectGiacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 10, 2025
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosisGaetano Paride Arcidiacono, Marco Onofrio Torres, Francesca Zanchetta, et al.
Cancer Medicine|August 31, 2021
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general populationMassimiliano Bonifacio, Mario Tiribelli, Maria Cristina Miggiano, et al.
British Journal of Haematology|November 6, 2022
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL studyMichelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, et al.
The Lancet. Haematology|January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling studyJavier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Haematologica|January 15, 2026
Real-life management of 476 older adults with Philadelphianegative acute lymphoblastic leukemia: a Campus ALL studyMarco Cerrano, Davide Lazzarotto, Eleonora Boscaro, et al.
Blood Advances|September 12, 2022
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E Kennedy, Cecelia Perkins, Andreas Reiter, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
British Journal of Haematology|September 13, 2023
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL studyDarina Ocadlikova, Federico Lussana, Nicola Fracchiolla, et al.
Cancer Medicine|January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA ProjectGiacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 10, 2025
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosisGaetano Paride Arcidiacono, Marco Onofrio Torres, Francesca Zanchetta, et al.
Cancer Medicine|August 31, 2021
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general populationMassimiliano Bonifacio, Mario Tiribelli, Maria Cristina Miggiano, et al.
British Journal of Haematology|November 6, 2022
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL studyMichelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, et al.
The Lancet. Haematology|January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling studyJavier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Haematologica|January 15, 2026
Real-life management of 476 older adults with Philadelphianegative acute lymphoblastic leukemia: a Campus ALL studyMarco Cerrano, Davide Lazzarotto, Eleonora Boscaro, et al.
Blood Advances|September 12, 2022
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E Kennedy, Cecelia Perkins, Andreas Reiter, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Pageof 3